Pfizer Buys Biohaven for US$11.6 B
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 5 (Table of Contents)
Published: 13 May-2022
DOI: 10.3833/pdr.v2022.i5.2690 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In the biggest buyout of 2022 so far, Pfizer has agreed to acquire Biohaven Pharmaceutical for US$148...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS